ClinicalTrials.Veeva

Menu

Neuramis® Deep Lidocaine Compared to YVOIRE® Volume Plus for Correction of Nasolabial Folds

Medytox logo

Medytox

Status

Completed

Conditions

Nasolabial Folds

Treatments

Device: experimental
Device: comparator

Study type

Interventional

Funder types

Industry

Identifiers

NCT03753152
MT07-CN16NLF701

Details and patient eligibility

About

This clinical investigation is a randomized, evaluator-blind, active controlled, noninferiority study to evaluate the effectiveness and safety of Neuramis® Deep Lidocaine when compared with YVOIRE® Volume Plus.

Full description

Males or females between 18 and 75 years of age, who want to correct both NLFs with 3 or 4 points in the WSRS and who provided written informed consent are to be included in the investigation.

Enrollment

370 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Male or female, 18 to 75 years of age.
  2. Subjects who desire correction of bilateral NLFs that are rated as 3 or 4 points on the WSRS.

Exclusion criteria

  1. Subjects who have received anticoagulation, antiplatelet, or thrombolytic medications, anti inflammatory medications.
  2. Subjects who had soft tissue augmentation, medium or deep peeling, or dermal photorejuvenation on the lower inferior orbital rim for wrinkle correction.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

370 participants in 2 patient groups

Investigational medical device
Experimental group
Description:
Neuramis® Deep Lidocaine
Treatment:
Device: experimental
Comparator device
Active Comparator group
Description:
YVOIRE® Volume Plus
Treatment:
Device: comparator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems